The term biobank refers to a collection of human samples, such as blood, urine or tissue, that has been collected for the purpose of scientific research and/or clinical treatment. Donors can be patients as well as healthy individuals. Biobanks contain valuable information on the donor of the sample, for example on clinical outcome, medical status, genetic characteristics, socio-economic status or lifestyle. Access to these collections can be crucial for companies developing novel diagnostics or therapeutics.
“My research interest focuses on biomarkers for Alzheimer’s and Multiple Sclerosis. For these two diseases, VUmc manage renowned biobanks that generate a lot of interest, especially from the pharmaceutical industry. We are willing to grant companies access to our biobanks for projects that are in line with our own goals. The reason is simple. We want our research to benefit patients, so the more our data and expertise are used, the better. But that doesn’t mean we give it all away for free. All this knowledge has been gained thanks to public funding, so we expect commercial parties to pay a fair fee. The IXA team supports us in such negotiations and draws up the contracts, but they do more than that. Together, we also identify and actively approach companies that may benefit from our biobanks. I know from experience that there is a lot of added value in operating together. They contribute relevant perspectives that we don’t have. Working with the team on a variety of projects, I have learned that they offer a lot more expertise than is obvious at first sight.”
Charlotte Teunissen, Head of Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VUmc
AMC clinical physiologist Peter Sterk’s idea to explore the use of e-nose technology for diagnosis of lung disease has really payed off. His brand-new ‘SpiroNose’ breath analyser will shortly become available for hospitals and general practices. Sterk is confident about the clinical validation studies that are now underway: “The SpiroNose will be a formidable addition […]
About three years ago orthopaedic surgeon Olivier Temmerman approached the Physics and Medical Technology (FMT) department of VUmc. He had an idea to improve the surgical chisel for removing old cementing layers during hip prosthesis revisions. It was ‘a real pearl’ according to Micha Paalman, head of the development group at FMT. “Olivier had worked […]
How to make an impact with your research and what does it take to go from idea to product or service. Watch the video of Sue Gibbs, regenerative medicine ACTA / Amsterdam UMC. She explains how her research contributed in making a lasting impact.